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NAi, a general tool for targeted gene knockdown in mammalian cells, is carried out using synthetic siRNA duplexes or vectors expressing shRNA. shRNA is processed by enzyme Dicer to yield siRNA, which is incorporated into the RNA-induced silencing complex (RISC). RISC containing the guide (antisense) strand of siRNA causes endonucleolytic cleavage of target mRNA (1) . Synthetic siRNA duplexes and shRNA templates are usually developed through rational design based on sequencebased rules that undergo continuous modification and optimization (2) . The efficacy of the published rules for siRNA design remains controversial, and their applicability to shRNA is still uncertain (3) .
As a tool for identifying genes, inhibition of which confers a selectable phenotype, several groups have generated expression libraries comprising vectors that express synthetic shRNA sequences targeting thousands of genes, typically at three to six different shRNAs per gene (4) (5) (6) (7) (8) (9) (10) . Such libraries have been used for several types of selection to identify genes, knockdown of which produces a selectable phenotype. Designed shRNA libraries, however, are very expensive and time-consuming to generate for any new organism, and are limited to known genes and splice variants. Additionally, such libraries are not necessarily able to inhibit every gene they target, because the current status of shRNA design provides no assurance that the small number of shRNAs per gene will include active inhibitors.
An alternative strategy for shRNA library construction is enzymatic conversion of randomly fragmented cDNA into templates for shRNA (11) (12) (13) (14) (15) (16) (17) . A significant drawback of large-scale shRNA libraries derived from cellular cDNA is that the relative abundance of shRNA sequences is proportional to the starting mRNA they target. This variation among individual shRNAs makes it difficult to inhibit lower-abundance mRNAs. A second problem with enzymatically generated libraries is that their large size and undefined composition preclude the use of an efficient "molecular barcoding" approach (6-10) for rapid identification of enriched or depleted sequences.
In the present article, we describe a general strategy for functionbased gene identification, applicable to essentially any organism and independent of the status of shRNA design rules. This strategy involves (i) enzymatic generation of transcriptome-scale shRNA libraries with relatively even representation of different genes, (ii) expression selection of functional shRNAs using a regulated lentiviral expression vector, (iii) identification of sequences enriched by selection through massive parallel sequencing, and (iv) validation of shRNA targets identified by selection using synthetic siRNAs. Structure-activity analysis of multiple clones from such a library enabled us to identify the significant parameters associated with determining shRNA activity. We also demonstrate the utility and effectiveness of this strategy for identifying genes required for breast carcinoma cell growth, for which this strategy yielded genes and pathways implicated in cell growth and cancer, potential targets for anticancer drugs.
Results and Discussion shRNA Library Construction. Our strategy for enzymatic generation of shRNA templates is schematized in Fig. 1A and described in SI Methods. DNase I digestion of target DNA is used to generate random double-stranded fragments (step 1), followed by ligation of the ends of these fragments to a single-stranded adaptor that forms a hairpin (step 2). The hairpin adaptor (HA; Fig. S1A ) contains the loop from mir-23 miRNA and a recognition site for restriction enzyme MmeI, which cuts within the cDNA sequence 18-20 nt away from its recognition site, producing a targeting sequence of a size suitable for shRNA (step 3). The MmeI-generated fragments with 3′ NN overhangs are then ligated to a second adaptor (the termination adaptor, TA; Fig. S1A ) (step 4), which provides an internal primer for subsequent extension (step 5). Parts of TA sequences are then removed by restriction enzyme digestion (step 6) to generate shRNA templates containing an inverted repeat followed by Pol III termination signal; the templates are then ligated into an expression vector to produce a library (step 7).
The principal differences between this strategy and earlier protocols (11, 12, (12) (13) (14) (15) (16) ) are as follows. (i) We use a much shorter HA, which is retained in the final shRNA library without truncation. The adaptor-derived stem sequence, joined to 19-21 bp of cDNA sequence, produces a total hairpin stem length of 27-29 bp, the size that produces more efficient knockdown (18) .
(ii) The design of the TA (Fig. S1 ) provides a Pol III termination signal and a 3′ (G/A)N overhang that places a purine at the +1 position relative to the promoter improving Pol III transcription (19) and includes a single-stranded nick that primes the extension with Klenow fragment (Fig. 1A, step 5 ), without the need for an external primer. (iii) The library is constructed in a tightly regulated lentiviral vector LLCEP TU6LX (Fig. 1B) , an optimized version of our previously described vector LLCEP TU6X, which is regulated by tetracycline/doxycycline via tTR-KRAB repressor (20) . The use of this vector for shRNA expression prevents the loss of growth-inhibitory sequences and allows for precisely controlled shRNA activity measurements.
The library construction strategy was first tested on the GL2 firefly luciferase gene, randomly fragmented with DNaseI. Approximately 90% of 700 clones sequenced from the luciferasederived shRNA library contained proper shRNA structures comprising unique 19-21-bp sequences of the luciferase gene. To generate a human transcriptome library and to overcome the problem of uneven representation of different genes in conventional cDNA, we took advantage of the process of cDNA normalization that equalizes the abundance of different mRNA sequences (21) . As the starting material for shRNA library construction, we used a library originally developed for the selection of genetic suppressor elements (GSE, short cDNA fragments encoding either antisense RNA or protein fragments acting as transdominant inhibitors). The GSE library was derived from randomly fragmented cDNA of MCF7 human breast carcinoma cells, normalized by C o t fractionation (21) . The GSE library construction strategy (22) favored directional cloning of cDNA fragments flanked by different adaptors at the 5′ and 3′ ends relative to the original mRNA; sequence analysis of representative clones showed that approximately two thirds of the clones contained the adaptors in the preferred orientation. Partial directionality of the GSE library offered a possibility of creating an shRNA library where most of the shRNA sequences would have 5′-sense-loopantisense-3′ (SA) strand orientation, which seemed desirable owing to the reports that shRNA sequences with 5′-antisense-loopsense-3 (AS) orientation were less effective (11, 12) . We replaced the 3′ adaptor of normalized cDNA fragments from the GSE library with the HA, with the subsequent steps of library construction the same as in Fig. 1A .
The shRNA library from normalized cDNA contained a total of 2.8 × 10 6 clones. Sequence analysis of 676 randomly picked clones showed that 632 of them (93.5%) contained proper stemand-loop inserts. Of these, 500 clones (79.1%) matched with the UniGene transcript database and targeted 461 UniGene entries. Another 76 clones (12.0%) matched human genome sequences but not sequences within the UniGene database, and are likely to represent as-yet-unidentified transcripts. Of the sequenced clones, 68.2% had SA orientation and 31.8% had AS orientation, as in the starting GSE library. The length distribution of the targeted cDNA sequences was 52.4% 20 bp, 46.8% 21 bp, and 0.8% 19 bp, reflecting the heterogeneity of MmeI digestion.
To estimate the normalization and representativity of the shRNA library, we have analyzed the distribution of shRNA sequences identified by massive parallel sequencing of inserts recovered from genomic DNA of cells transduced with the library (see below). A total of 53,201 shRNAs corresponding to 14,699 UniGene entries were identified, with 72% of the entries differing in representation no more than 3-fold. Fig. 1C displays RNA expression [signal intensity in microarray hybridization (23) ] in MCF7 cells for ≈24,000 probe sets representing all of the UniGene entries in the microarray (one probe set per entry), plotted in the order of increasing expression, as well as for probe sets representing UniGene entries identified in our library.
Comparison of the two curves shows that genes expressed at the highest and the lowest levels in MCF7 cDNA have similar representation in the library, whereas the genes with intermediate levels of expression are moderately overrepresented (Fig. 1C) . Hence, our library provides relatively uniform representation of at least ≈15,000 genes, at the average of >150 shRNAs per gene.
Activity Assays of Luciferase-Derived and cDNA-Derived shRNAs. The use of an inducible promoter for shRNA expression allows for precisely controlled measurement of RNAi activity, by comparing target expression levels in the presence and in the absence of the inducer. To generate data for shRNA structure-activity analysis, we carried out high-throughput assays of target knockdown by randomly picked clones from both luciferase-and cDNA-derived libraries, as schematized in Fig. S2A . The luciferase-derived clones were assayed for luciferase activity knockdown in HT1080 human fibrosarcoma cells expressing GL2 luciferase, as determined by comparing normalized luciferase activity in the presence and in the absence of doxycycline. Fig. 2A shows luciferase knockdown in 230 cell populations corresponding to 201 different shRNA sequences. Thirty-five percent and 11% of the clones produced >50% and >75% knockdown, respectively. Although none of the clones showed >90% knockdown in this assay, the knockdown efficiency was lowered in this assay by the relatively low lentiviral transduction rate in 96-well plates [low transduction leads to lower transgene expression in drug-selected populations (24) ]. In the experiment shown in Fig. 2B , 96 clones representing a range of RNAi activities were retested by more efficient transduction in 24-well plates, along with the vector expressing a commercially available highly efficient reference shRNA for GL2 luciferase. The knockdown rates in Fig. 2B were calculated for each shRNA in the presence of doxycycline relative to cells transduced with insertfree vector. This analysis showed higher knockdown rates and an overall concordance with the data in Fig. 2A (Pearson correlation coefficient 0.81, P = 2 × 10 −16 ) (Fig. S2B) . The reference shRNA produced 90% knockdown, and this efficiency was exceeded by 15 of 96 clones generated from random fragments (Fig. 2B) . Hence, random fragment conversion can produce shRNA inhibitors that are at least as efficient as rationally designed shRNA.
To evaluate RNAi activity of shRNA clones derived from normalized cDNA, we analyzed 101 cell populations transduced with clones corresponding to 100 different UniGene entries for a decrease in the RNA level of genes targeted by each shRNA. This analysis was performed by quantitative RT-PCR (QPCR) with gene-specific primers using RNA from cell populations grown with or without doxycycline. The distribution of RNAi activities (Fig.  2C) shows that 10% of the tested clones produced ≥50% knockdown by this criterion. Immunoblotting analysis for four of the protein targets of shRNAs that produced ≈50% knockdown in mRNA levels showed a decrease in the corresponding protein levels, which was in some cases much stronger than the mRNA decrease measured by QPCR (Fig. 2D) . The lower apparent frequency of effective inhibitors among cDNA-derived shRNAs than among luciferase-derived shRNAs could reflect higher sensitivity of the artifical GL2 luciferase transcript to RNAi relative to human mRNAs. Alternatively, the difference could be due to lower sensitivity of the QPCR assay relative to the protein activity assay or to different RNAi activities between the cell lines (HT1080 and MCF7) in which these clone sets were tested. Indeed, we were able to achieve only ≈75% luciferase knockdown with the reference shRNA in MCF7 cells, as opposed to >90% knockdown in HT1080 cells. Assuming 10% frequency of active shRNAs and ≈150 shRNAs per gene, an average gene in the library should be represented by ≈15 active shRNAs.
Structure/Activity Analysis of shRNA Sequences. We investigated whether commonly used criteria for shRNA design, namely the choice of SA over AS orientation of shRNA and the Dharmacon score [a cumulative score for several criteria based on the sequence of the 19-nt siRNA guide strand (25) ], show activity correlations with our datasets of 201 luciferase-derived and 101 cDNA-derived shRNA activities. The distributions of shRNA activities of both datasets according to the shRNA orientation and the Dharmacon score are shown in Fig. 3A . SA orientation was associated with higher activity in both datasets, but this difference was significant only for the luciferase dataset (P = 0.0002 for luciferase and P = 0.1137 for cDNA dataset, Welch's t test). Dharmacon score showed significant correlation with activity in both datasets [Spearman correlation 0.26 (P = 0.0002) for luciferase and 0.27 (P = 0.0062) for cDNA dataset]. Nevertheless, the majority of active shRNAs in both datasets showed relatively low Dharmacon scores (≤7), and surprisingly, many AS-oriented shRNAs were highly active (Fig. 3A) . Therefore, we have conducted a structure-activity analysis (SI Methods) by including the following parameters (Table S1 ): the effects of the shRNA length and orientation, the levels of gene expression, the role of individual bases at each position in shRNA (Fig. S2B) , the presence of runs of identical nucleotides, and five energy parameters based on the structures of both the processed shRNA and its mRNA target calculated using the Sfold algorithm (26) . The goal of the analysis was to identify the parameters and cutoff values (filtering criteria) associated with RNAi activity.
Most of the tested parameters, including secondary structure formation by siRNA guide strand, siRNA target binding energy, average internal stability at the cleavage site, and levels of gene expression (for the cDNA-derived dataset), showed no correlations with shRNA activity. The filtering criteria that produced significant activity discrimination in both datasets are presented in Figs. S3, S4, S5, and S6. The preferences identified in both cDNA and luciferase sets include (i) the SA orientation in those shRNAs that contain G as the first base; (ii) absence of runs of three G, three C, or four A nucleotides anywhere within the shRNA transcript, or three U nucleotides preceding the first U of the termination signal; (iii) GC content between 35% and 60%; (iv) The free-energy difference between the 5′ and the 3′ ends of the processed siRNA guide strand characterized by DSSE (differential stability in siRNA duplex ends) values of ≤−1 kcal/mol; and (v) the absence of C in the second position of the guide strand (Fig. S2B) . As presented elsewhere (27) , we have also found that the activity in the cDNA dataset was significantly correlated with target disruption energy, a measure of accessibility of the target mRNA. cDNA-derived shRNAs showed lower activity when their disruption energy was <−15 kcal/mol, which we have used as the sixth filtering criterion. Target disruption energy was also found to be significant in independent siRNA datasets from three human genes (27) but did not correlate with RNAi activity in the luciferase dataset, suggesting that luciferase inhibition by RNAi does not depend on the accessibility of individual sequences within this artificial target. Fig 3B compares the activities of shRNAs that either passed or failed the combination of the first five filtering criteria (excluding target disruption energy) or all six filters (the comparisons for individual filters are shown in Fig. S3 ). After applying the first five filters, the fraction of luciferase-derived shRNAs that inhibit luciferase activity >2-fold increased from 34% in the unfiltered set to 71%. The active cDNA-derived shRNAs, defined as those that decrease target mRNA >2-fold by QPCR, increased from 10% to 40%. The addition of the target disruption energy filter produced an additional improvement in the cDNA dataset, increasing the active fraction to 50% (6 of 12) and allowing us to identify five of six most active shRNAs. Future analysis of additional clones from the cDNA-derived library should yield other significant correlations that will allow for even more rigorous selection of active shRNAs.
Identification of Genes Required for Breast Carcinoma Cell Growth Through Growth-Inhibitory shRNA Selection and Massive Parallel
Sequencing. Genes required for the cell growth are expected to give rise to shRNAs that would inhibit cell proliferation. Such inhibitors can be isolated through negative selection techniques, such as BrdU suicide selection, previously used to identify growth-inhibitory GSEs (22, 28) . We have now used our normalized cDNA library in the same selection (Fig. 4A) , taking advantage of the massive parallel sequencing technology for identifying sequences enriched in selection.
The scheme of this analysis strategy is presented in Fig. 4B . The shRNA library was transduced into 2.5 × 10 7 MDA-MB-231 breast carcinoma cells expressing tTR-KRAB. 25% of the cells were used for DNA extraction, and the rest were selected for doxycyclinedependent resistance to BrdU suicide. Cells surviving the selection were used for DNA extraction. The integrated shRNA templates were amplified by PCR from genomic DNA extracted from the unselected and the BrdU-selected library-transduced cells using vector-specific primers, and the PCR product was subjected to 454 pyrosequencing. BLAST analysis of the sequence data yielded 53,201 sequences with homology to Unigene database entries before selection and 53,803 sequences after selection. These sequences matched 14,699 and 3,316 Unigene clusters respectively, indicating that selection has occurred. Sequences of 741 genes in the selected subset were enriched at least 4-fold after selection, and one of the most enriched genes was KRAS, an oncogene that has undergone an activating mutation in MDA-MB-231 cells (29) . Table 1 shows the top 10 Kyoto Encyclopedia of Genes and Genomes pathways that were significantly enriched in this group of genes, as determined using the Pathway-Express program (30) . Strikingly, 9 of the 10 pathways were associated with various cancers, cell cycle progression, or apoptosis. This analysis validates our selection system as capable of identifying oncogenes.
Of the identified genes, 119 were targeted by two to six different enriched shRNA sequences and therefore represent the most likely targets. These genes, among which KRAS showed the strongest enrichment, are listed in Table S2 . To verify the role of such genes in cell growth, we have picked 22 of the most enriched genes represented by at least two selected shRNA sequences and 12 genes that showed no change in shRNA representation after selection. Instead of the laborious process of individually assaying specific shRNAs enriched by selection, we tested the role of candidate genes in cell growth by an independent procedure, based on transfection with synthetic siRNAs (designed by Qiagen), to determine whether such siRNAs will inhibit cell growth. Individual siRNAs were transfected into MDA-MB-231 cells, at four siRNAs per gene. A cytotoxic mixture of siRNAs derived from several essential genes was used as a positive control, and siRNAs targeting either no known genes or GFP were used as negative controls. Relative cell number was determined 6 days after siRNA transfection. As shown in Fig. 4C , one to four siRNAs per gene, targeting 19 of 22 tested genes (86%), inhibited cell growth relative to the negative controls (P values <0.05 for 17 genes and 0.053 and 0.07 for two other genes); KRAS targeting siRNAs showed the strongest effect. In contrast, none of the siRNAs in the control group of 12 genes with unchanged shRNA representation inhibited cell growth (Fig. 4D) . Hence, the use of an enzymatically generated shRNA library coupled with BrdU suicide selection, massive parallel sequencing, and target verification by synthetic siRNAs, provides for efficient identification of genes required for cell growth. The analysis strategy of the present study should be generally applicable to high-throughput identification of genes involved in many different phenotypes. 
Methods
All of the procedures are described in detail in SI Methods. The coding sequence of GL2 firefly luciferase from pGEM-luc vector (Promega) was used to generate the luciferase-based library. The starting material for the cDNA-based library was a GSE library of normalized cDNA fragments from MCF7 breast carcinoma cells, prepared as described previously (22) . The lentiviral vector LLCEP TU6LX is an optimized version of LLCEP TU6X (20) .
The scheme of the high-throughput activity assays of individual shRNA clones is shown in Fig. S2 . Luciferase activity assays were carried out in human HT1080 fibrosarcoma cells expressing GL2 luciferase and tTR-KRAB repressor with DsRed fluorescent protein. Human gene knockdown assays were carried out in MCF7 breast carcinoma cells expressing tTR-KRAB, by QPCR. To select growthinhibitory shRNAs, the cDNA-based library was transduced into MDA-MB-231 breast carcinoma cells expressing tTR-KRAB repressor and subjected to selection for doxycycline-dependent resistance to BrdU suicide. The shRNA sequences, amplified by PCR from the DNA of the unselected and BrdU-selected cells using vector-specific primers, were subjected to ultra-high throughput sequencing using the 454 Sequencing System. For siRNA verification assays, four siRNAs per gene (Qiagen), along with control siRNAs, were transfected into MDA-MB-231 cells in 96-well plates, in triplicates, at 5 nM of siRNA per well. Relative cell number was determined 6 days after siRNA transfection by staining cellular DNA with Hoechst 33342. The Student t test (one-tailed, unequal variance) was used for assessing statistical difference between the inhibitory effects of tested and control siRNA. Sequencing of plasmid DNA from randomly picked colonies was carried out on ABI 3730. Attribution of shRNA sequences was performed using National Center for Biotechnology Information BLAST and Java and Perl programs written for this analysis. Clone representation was correlated with the data from Affymetrix U133 Plus2.0 microarrayanalysisofgene expressioninexponentiallygrowingMCF7cells (23), using GeneSpring (Agilent). Different parameters used for shRNA structureactivity analysis were computed using the Sfold program (26) . Plotting of the calculated parameters and nucleotides at each position in the guide strand, as well as statistical analysis, was carried out using R 2.3.1 software.
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SI Methods
Vectors. Doxycycline-regulated lentiviral vector LLCEP TU6LX (Fig. 1B in main text) regulated by doxycycline via tTR-KRAB repressor (1), was derived from LLCEP TU6X (2), which was modified by mutagenizing the 3′ end of human U6 promoter to create an SrfI site. The SrfI site and the downstream XbaI site were then used to clone a modified cassette comprising CAT gene (chloramphenicol resistance) and bacterial toxin ccdB (a negative selection marker), derived from Gateway Reading Frame Cassette A (Invitrogen). The vector was propagated in Escherichia coli strain DB3.1 (Invitrogen) resistant to ccdB, in the presence of ampicillin and chloramphenicol. As a positive control for luciferase-derived shRNA, we inserted the GL2 luciferase targeting shRNA from pSIREN Control Vector Set (Clontech) into LLCEP TU6X. tTR-KRAB repressor was expressed either from dsRed-expressing lentiviral vector pLV-tTR-KRAB-red (1), or from a vector termed LFC-tTR-KRAB, which was derived by replacing luciferase with tTR-KRAB in the lentiviral vector pLFC-GL2 (2) that carries a blasticidin resistance marker.
Cell Lines. HT1080 cells were cultured in DMEM with 10% FC2 serum (Invitrogen) supplemented with penicillin, streptomycin, and glutamine. 293FT cells (Invitrogen) were cultured in DMEM with 10% FC2 supplemented with penicillin, streptomycin, glutamine, and nonessential amino acids. MCF7 cells were cultured in DMEM with 10% FBS (Invitrogen) supplemented with penicillin, streptomycin, glutamine, sodium pyruvate, nonessential amino acids, and insulin. To generate recipient cell line for luciferase assays, HT1080 fibrosarcoma subline E14 (3) was transduced with retroviral vector LNCLuc (4) expressing GL2 luciferase and selected with 800 μg/mL G418. The cells were then transduced with pLV-tTR-KRAB-red and selected for DsRed fluorescence by flow sorting using FACSAria (Becton Dickinson). To generate recipient cells for regulated human gene knockdown, MCF7 and MDA-MB-231 breast carcinoma cell lines were obtained from American Type Culture Collection and then infected with LFC-tTR-KRAB and selected with 6 μg/mL blasticidin (MCF7) or infected with pLVtTR-KRAB-red followed by two rounds of FACS selection for DsRed positive cells (MDA-MB-231). To test for tetracycline/ doxycycline-dependent regulation, tTR-KRAB-transduced cells were infected with an enhanced green fluorescent protein (EGFP)-expressing tetracycline/doxycycline-inducible pLLCEm-GFP lentiviral vector. The level of activation of EGFP expression by treatment with 100 ng/mL doxycycline was approximately 150-fold.
shRNA Library Construction from GL2 Luciferase. Coding sequence of GL2 firefly luciferase was amplified by PCR from pGEM-luc vector (Promega) and digested with DNase I (Amersham/GE Healthcare) as described previously (5) to produce 50-400-bp fragments, the ends of which were then ligated to hairpin adaptor (HA) (Fig. S1A) . HA contains MmeI restriction site and the loop of mir23 miRNA. After digestion with MmeI restriction enzyme (New England Biolabs), HA-containing fragments migrating at ≈32-34 bp were purified by electrophoresis in a 10% TBE-polyacrylamide gel, and their MmeIgenerated 3′ NN overhangs were ligated to termination adaptor (TA) (Fig. S1A) . TA contains a single-stranded nick that primes the extension with Klenow fragment (Fig. 1A in main text, step 5) , without the need to denature the hairpin and anneal an external primer. TA also provides a Pol III termination signal and a 3′ (G/A)N overhang, which improves Pol III transcription by placing a purine at +1 position from the promoter (6) . Primer extension from the primer within TA was performed with Klenow fragment of DNA polymerase I (Fermentas). Extended fragments (139-143 bp long) were purified on an 8% Tris/borate/EDTA (TBE)-polyacrylamide gel and digested with MlyI and XbaI restriction enzymes. The ≈78-80-bp digestion product was purified on an 8% TBE-polyacrylamide gel and then ligated into the LLCEP TU6LX backbone, which had been prepared by gel purification of plasmid digested with SrfI and XbaI to remove the CAT-ccdB cassette. The resulting library was transformed into ccdB-sensitive E. coli 10G Supreme (Lucigen), which selects for ccdB-free insert-containing clones.
We have also generated another luciferase-derived shRNA library using a modified TA that was designed to shorten the shRNA stem by removing a nucleotide at the 5′ end of the shRNA transcript and leaving an unpaired cDNA-derived nucleotide at the 3′ end of the shRNA. Subsequent analysis showed no difference in shRNA activity between the two adaptors.
Library Construction from Normalized Human cDNA Fragments. A genetic suppressor elements (GSE) library of normalized cDNA fragments from MCF7 breast carcinoma cells was prepared as described previously (7) and cloned in retroviral vector LmGCX (3) . cDNA inserts with their flanking 5′ and 3′ adaptors were amplified from the GSE library by PCR using adaptor-derived primers. The primer corresponding to the 5′ adaptor was biotinylated, and the primer corresponding to the 3′ adaptor was sequencemodified to create an MmeI site at a position that allows for MmeI digestion within the cDNA sequence after random octanucleotide reverse transcription priming site. At the next step, MmeI digestion was used to remove the adaptor and the octanucleotide-derived sequence, generating a two-nucleotide NN overhang at the 3′ end. The MmeI-digested 100-500-bp fragments were gel-purified and ligated with HA, which was the same as in Fig. S1A except for the addition of a NN overhang at the 3′ end. The ligated material was bound to Dynabeads M-270 Streptavidin magnetic beads (Invitrogen/Dynal) and digested at the MmeI site in the HA, so that fragments containing the HA and 19-21 bp of cDNA sequences could be separated from fragments containing the 5′ adaptor, which remained bound to the streptavidin beads. The purified fragments were then used for ligation with TA and subsequent steps of shRNA template generation, as described for the luciferasederived library.
Sequence Analysis. For sequence analysis of individual library clones, individual bacterial colonies were picked at random and grown in 2-mL cultures in 96-well deep culture blocks (Whatman). Plasmid DNA was isolated using either Wizard SV 96 Plasmid DNA Purification System (Promega) or QIAprep 96 Miniprep Kit (Qiagen) and sequenced on an ABI 3730 DNA Analyzer using a 1-5 ratio of BigDye 3.1 dGTP dye terminator and BigDye 3.1 Dye terminator mixtures. For massive parallel sequencing, PCR-amplified shRNA templates were subjected to ultra-high-throughput sequencing by 454 Life Science.
Sequence attribution of shRNA sequences was performed using National Center for Biotechnology Information (NCBI) BLAST (standard default "blastn" settings) against NCBI's human genome database located at ftp.ncbi/nih/gov/respository/Unigene/Homo_ sapiens/. The first program utilizes the BioJava version 1.4 framework (http://www.biojava.org) and NCBI BLAST software to process chromatogram and sequence data generated by DNA sequencing and base calling software, and it allows exploration of sequencing and analysis results in 96-well format using a graphical user interface. The program uses BLAST to identify correctly structured library shRNA clones and to identify target mRNAs in NCBI BLAST-formatted sequence databases, with a special emphasis on identification of targets using the NCBI UniGene cluster database. For the attribution of batch sequence data from ultrahigh-throughput sequencing, the best "high-scoring segment pairs" or HSPs (i.e., those with the lowest E-value) were extracted using a custom Perl script using BioPerl modules. Only those HSPs that fell within 4 nt of the estimated start of the nonadaptor portion of the sequence were scored as legitimate hits.
To characterize the library representation of genes with different levels of expression in MCF7 cells, we have used the data from Affymetrix U133 Plus 2.0 microarray analysis of gene expression in exponentially growing MCF7 cells (8) with Microsoft Excel and GeneSpring software (Agilent). The probe sets in the Affymetrix array were matched with their corresponding UniGene ID numbers, and one probe set per UniGene entry was selected on the basis of the highest raw hybridization signal in MCF7 cells. The same selection was carried out for UniGene entries identified by sequence analysis in cDNA-derived shRNA library. The resulting lists of probe sets were then plotted against the raw hybridization data and signal significance values using GeneSpring.
shRNA Activity Analysis. After sequence analysis, plasmid clones were selected and arrayed into 96-well plates using a SciClone ALH 3000 Workstation (Caliper) and adjusted by addition of water to a fixed concentration. Ninety-six-well transfection of lentiviral vectors into 293FT packaging cells was performed using TransFectin Lipid Reagent (Bio-Rad). Two hundred nanograms of plasmid DNA for each library clone or control clone was transferred to a sterile 96-well round-bottom plate and combined with 200 ng of Δ8.91 lentiviral packaging plasmid and 66 ng VSV-G plasmid (gifts of Dr. I. Verma, Salk Institute) in serumfree DMEM. TransFectin reagent diluted in serum-free DMEM was added to allow formation of lipid complexes. After complex formation, 50,000 293FT cells in DMEM with 10% FC2 were added to each well. After overnight incubation, media were removed, and 125 μL fresh media were added. On the next day, plates were centrifuged, and 60 μL of virus-containing media were removed from each well. The media were added to the recipient cells, plated the day before at 2,500-5,000 cells per well in 96-well flat-bottom plates, and treated with 50 μM chloroquine before transduction. Transduction was repeated the following day. Two days after last transduction, transduced cells were treated with 100 ng/mL doxycycline for 2 days to induce EGFP-Puro expression, and selected with 2 μg/mL puromycin for 2 to 3 days. After selection, cells were passaged either in 96-well or in 24-well plates.
For luciferase assays, cells were plated in opaque black Nunclon Delta 96-well plates (Nalge/Nunc). Cell numbers were equalized using DsRed fluorescence as measured by FluoStar Optima multifunction plate reader (BMG Labtech). Doxycycline (100 ng/mL) or media without doxycycline were added for 2 days, then cells were washed three times with PBS and lysed in 25 μL of Passive Lysis Buffer (Promega). Firefly luciferase activity was measured using Promega Luciferase Assay System and normalized by DsRed fluorescence, measured in the same wells with the plate reader before luciferase measurement. Each plate was assayed three times on separate days.
For quantitative RT-PCR (QPCR) analysis, microarray data for MCF7 cells was examined to determine which targets were likely to be expressed at a detectable level. In addition, we selected shRNAs that target mRNAs for which QPCR primer sequences are available at PrimerBank database (http://pga.mgh. harvard.edu/primerbank/). Cells of each shRNA-transduced population were plated in two wells of 96-well plates, one of which contained 100 ng/mL doxycycline. After 3 days, poly(A)+ RNA was isolated using TurboCapture 8 mRNA strips (Qiagen) and converted into cDNA by reverse transcription using random hexanucleotide primers and SuperScript III reverse transcriptase (Invitrogen). QPCR was carried out in triplicate using an ABI 7900HT real-time PCR instrument, with primers for corresponding to each target gene selected from PrimerBank database (9) . RNA levels normalized relative to β-actin were calculated using a modified ΔΔC T method that took into account the amplification efficiency for each primer set, using QPCR SDS software (ABI) and the LinRegPCR program (10) .
For immunoblotting analysis, MCF7 cells carrying individual shRNAs were grown for 3 days in the presence or absence of 100 ng/mL doxycycline in P100 plates. Immunoblotting analysis was carried out by standard procedures. Two-fold serial dilutions of protein extracts were used to assure the excess of the antibody. Primary antibodies against the corresponding shRNA targets were as follows: HIF2α (mouse monoclonal, Abcam ab8365), MCM2 (mouse monoclonal, Abcam ab6153); APC6 (rabbit polyclonal, Abcam ab18299); Aurora A (mouse monoclonal, EMD Biosciences, PK11). Immunoblots were developed using the corresponding HRP-conjugated secondary antibodies and ECL chemiluminescence agent. Image quantitation was carried out using the Bio-Rad VersaDoc imaging system. Structure-Activity Analysis. We have evaluated the shRNA length and orientation, the role of individual bases at each position in shRNA, the presence of runs of identical nucleotides, and five energy parameters based on the structures of both the processed shRNA and its mRNA target (Table S1 ). We took into account the fact that each shRNA can be cut by Dicer into two different siRNA sequences, with either a 19-nt or a 20-nt guide strand, at comparable yields (11) (Fig. S1B) , and carried out our calculations for both lengths. Dharmacon score, GC composition, differential stability in siRNA duplex ends (DSSE), minimum free energy (MFE) of the siRNA guide strand, siRNA binding energy, average internal stability (AIS) at the cleavage site (the average of internal stability values for positions 9-14 of the antisense strand (12)), and target disruption energy were computed with the Sfold algorithm (13) . DSSE is an Sfold implementation of the rule for asymmetry of duplex ends (12, 14) . MFE is the energy of the lowest-energy structure for the siRNA guide as computed by mfold (15) and is available from Sfold, and thus it measures the potential of siRNA self-folding. Dharmacon score is the sum of eight component scores for various sequence features of the siRNA duplex, with a range between −2 and 10 (16). Target disruption energy is a quantitative measure of target accessibility for the siRNA binding site and is based on mRNA secondary structures predicted by the Sfold program.
Correlations between shRNA activities and the above parameters, as well as effects of target sequence length, shRNA orientation, and individual nucleotides at each position in shRNA were plotted and analyzed using R software (http://cran.r-project. org/). Differences in shRNA activity of datasets that passed or failed filtering criteria were evaluated by statistical testing for twogroup comparison. The Welch's t test (two tailed) is used because the sizes of our datasets are sufficiently large, and this test does not rely on the assumption of equal variance.
Library Transduction and Selection for Resistance to BrdU Suicide.
The cDNA-derived shRNA library in pLLCE-TU6-LX vector was transduced into MDA-MB-231 breast carcinoma cells expressing tTR-KRAB. The infection rate (as determined by QPCR analysis of integrated provirus) was 95%. Twenty-five percent of the infected cells were subjected to DNA purification, and the rest were plated at a density of 1 × 10 6 cells per P150, to a total of 10 8 cells. These cells were subjected to selection for doxycycline-dependent resistance to BrdU suicide, as follows. Cells were treated with 0.1 μg/mL of doxycycline for 18 h, then with 0.1 μg/mL of doxycycline and 50 μM BrdU for 48 h. Cells were then incubated with 10 μM Hoechst 33258 for 3 h and illuminated with fluorescent white light for 15 min on a light box, to destroy the cells that replicated their DNA and incorporated BrdU in the presence of doxycycline. Cells were then washed twice with PBS and allowed to recover in normal medium (DMEM, 10% FBS) for 7-10 days. The surviving cells were collected, followed by DNA purification. The shRNA inserts were amplified by two rounds of PCR from genomic DNA preparations of the infected cells, unselected and BrdU-selected, using the following primers: shRNA-S (AAGGAATTCAAGG-TCGGGCAGGAAGAG), shRNA-AS (GGATCTAGACACG-GCCGCTCTAGACAAGTC), shRNA-454-seq-A (GCCTCCC-TCGCGCCATCAGTCAAGGTCGGGCAGGAAGAG), and shRNA-454-seq-B (GCCTTGCCAGCCCGCTCAGACGGCC-GCTCTAGACAAGTC).
Vector-specific primers shRNA-S and shRNA-AS were used for the first round of amplification, followed by the second round of amplification with primers shRNA-454-seq-A and shRNA-454-seq-B containing overhangs compatible with 454 A and B primers.
Amplified products were subjected to 454 ultra-high-throughput sequencing with 454 B primer.
Testing the Role of Target Genes in Cell Growth by siRNA Knockdown.
Four siRNAs per gene, obtained from Qiagen Human Whole Genome siRNA set 1.0, were transfected into MDA-MB231 cells in 96-well plates, in triplicates, at 5 nM of siRNA per well using Silentfect transfection reagent (Biorad) and the manufacturer's (Qiagen) instructions. A cytotoxic mixture of siRNA derived from several essential genes (Qiagen, All star cell death Hs siRNA, #1027298), was used as a positive control, and siRNAs targeting no known genes (Qiagen, Negative Control siRNA #1022076) or targeting GFP (Qiagen, GFP-22 siRNA, #1022064) were used as negative controls. Cells were cultured in DMEM media with 10% FBS serum, and the relative cell number was determined 6 days after siRNA transfection by staining cellular DNA with Hoechst 33342 (Polysciences, #23491-52-3). The calculations and interpretations of siRNA template binding energy, DSSE, AIS at the cleavage site, MFE of the siRNA guide strand, and the disruption energy of the target sequence are described in SI Methods. Pearson's correlation coefficients (PCC) and their corresponding P values are shown; an alternative nonparametric Spearman correlation analysis produced essentially the same results. *Significant correlation (P < 0.05).
